NPR Program Examines Brazil's Antiretroviral Program, Efforts To Collaborate With Other Countries To Fight HIV
Main Category: HIV / AIDSArticle Date: 17 Jun 2008 - 10:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
NPR's "Tell Me More" on Thursday included a discussion with Brazil's HIV/AIDS program director Mariangela Simao. Simao discussed progress in Brazil's no-cost antiretroviral program and the country's efforts to collaborate with Portuguese-speaking countries in Africa on HIV prevention.
According to Simao, 180,000 Brazilians are receiving no-cost antiretroviral treatment, one of the highest numbers among developing countries. An additional 15,000 to 17,000 people annually enroll in the treatment program, Simao said. Brazil aims to achieve universal access to HIV treatment and to make the country's antiretroviral program sustainable in the long term, Simao added.
Simao also discussed Brazil's efforts to provide materials on HIV/AIDS and collaborate on prevention activities with Portuguese-language speaking countries in Africa. According to Simao, the United Nations, Brazilian government, and health and women's affairs ministries from Portuguese-speaking countries met in Brazil last month to discuss ways to address HIV/AIDS and gender issues (Corley, "Tell Me More," NPR, 6/12).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/111550.php>
APA
http://www.medicalnewstoday.com/releases/111550.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



